Literature DB >> 6060020

Relapses of thromboembolic disease after discontinued anticoagulant therapy. A comparison of the incidence after abrupt and after gradual termination of treatment.

L Michaels, R E Beamish.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6060020     DOI: 10.1016/0002-9149(67)90010-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  5 in total

Review 1.  Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Anne Holbrook; Sam Schulman; Daniel M Witt; Per Olav Vandvik; Jason Fish; Michael J Kovacs; Peter J Svensson; David L Veenstra; Mark Crowther; Gordon H Guyatt
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Clinical evidence for rebound hypercoagulability after discontinuing oral anticoagulants for venous thromboembolism.

Authors:  David Keith Cundiff
Journal:  Medscape J Med       Date:  2008-11-11

3.  Recurrence of thromboembolic disease after discontinuing anticoagulant therapy. A study of factors affecting incidence.

Authors:  L Michaels
Journal:  Br Heart J       Date:  1970-05

4.  Locations and Mucosal Lesions Responsible for Major Gastrointestinal Bleeding in Patients on Warfarin or Dabigatran.

Authors:  Jennifer M Kolb; Kathryn Friedman Flack; Prapti Chatterjee-Murphy; Jay Desai; Lars C Wallentin; Michael Ezekowitz; Stuart Connolly; Paul Reilly; Martina Brueckmann; John Ilgenfritz; James Aisenberg
Journal:  Dig Dis Sci       Date:  2018-03-27       Impact factor: 3.199

Review 5.  Clinical pharmacokinetic considerations in the control of oral anticoagulant therapy.

Authors:  H G Shetty; A G Fennerty; P A Routledge
Journal:  Clin Pharmacokinet       Date:  1989-04       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.